Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Table 3 Multivariate linear regression model for serum cholesterol levels after 6 months of PI-therapy

Parameter	Coefficient	p-value	R^{2 a}
intercept	59.9	0.071
Therapy using ATV/r	reference
Therapy using SQV/r	34.5	0.007
Therapy using FPV/r	-83.8	0.15
FPV/r×BMI at baseline	5.6	0.021
BMI at baseline	1.5	0.26
Serum cholesterol at baseline	0.5	< 0.001
			0.49

ISSN: 2047-783X